|
2025
|
Invention
|
Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic subst... |
|
|
Invention
|
Treatment of alpha-synucleinopathies and neuroprotection. A method of treating an alpha-synuclein... |
|
2024
|
Invention
|
Nlrp3 inflammasome inhibitors. The present invention provides compounds of Formula (I), wherein a... |
|
|
Invention
|
Novel macrocyclic heteroaryl derivatives as kinase inhibitors. Macrocyclic heteroaryl derivatives... |
|
2023
|
Invention
|
Novel nlrp3 inflammasome inhibitors. The present invention provides compounds of Formula (I) : wh... |
|
|
Invention
|
Novel nlrp3 inflammasome inhibitors |
|
|
Invention
|
Jak1/jak2/tyk2 inhibitors for topical treatment of dermatological diseases. Provided 4-pyrazolyl-... |
|
|
Invention
|
Jak1/jak2/tyk2 inhibitors for topical treatment of dermatological diseases |
|
|
Invention
|
Nlrp3 inflammasome inhibitors.
Provided are compounds of Formula (I): wherein all of the variabl... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors. Provided are compounds of Formula (I): wherein all of the variable... |
|
2022
|
Invention
|
Method for synthesizing 1h-furo[3,2-b]imidazo[4,5-d]pyridine compound.
Provided is a method for ... |
|
|
Invention
|
Method for synthesizing 1h-furo[3,2-b]imidazo[4,5-d]pyridine compound. 22. The method for synthes... |
|
|
Invention
|
Method for synthesizing 1h-furo[3,2-b]imidazo[4,5-d]pyridine compound. Provided is a method for s... |
|
|
Invention
|
Methods of treating cns disorders.
Methods relate to treat a central nervous system (CNS) disord... |
|
|
Invention
|
Methods of treating cns disorders. Methods relate to treat a central nervous system (CNS) disorde... |
|
2020
|
Invention
|
Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, a... |
